Functional activity and tumor-specific expression of dual oxidase 2 in pancreatic cancer cells and human malignancies characterized with a novel monoclonal antibody

被引:38
|
作者
Wu, Yonghzong [1 ]
Antony, Smitha [1 ]
Hewitt, Stephen M. [2 ]
Jiang, Guojian [1 ]
Yang, Sherry X. [3 ]
Meitzler, Jennifer L. [1 ,3 ]
Juhasz, Agnes [1 ]
Lu, Jiamo [1 ]
Liu, Han [1 ]
Doroshow, James H. [1 ,3 ]
Roy, Krishnendu [3 ]
机构
[1] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[2] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[3] NCI, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
dual oxidase; NADPH oxidase; reactive oxygen species; pancreatic cancer; gene expression; GENE-EXPRESSION; HYDROGEN-PEROXIDE; NADPH OXIDASES; DUOX GENES; INFLAMMATION; PROTEINS; ADJACENT; TISSUES; ROS;
D O I
10.3892/ijo.2013.1821
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Dual oxidase 2 (Duox2), one of the seven members of the NADPH oxidase gene family, plays a critical role in generating H2O2, for thyroid hormone biosynthesis and as an integral part of the host defense system of the respiratory epithelium and the gastrointestinal tract. Recent evidence suggests that the regulation of Duox2 expression is under the control of pro-inflammatory cytokines and that Duox2-induced reactive oxygen species (ROS) contribute to the inflammation-related tissue injury that occurs in two pre-malignant, inflammatory conditions: chronic pancreatitis and inflammatory bowel disease. Because no reliable Duox antibodies are commercially available, we report the development of a murine monoclonal antibody (MAb) to Duox2 (clone Duox S-12) and its use for the characterization of Duox2 expression in human tumors, tumor cell lines and normal tissues. Duox S-12 specifically detected both endogenously- and ectopically-expressed Duox2 protein by immunoblotting, immunofluorescence microscopy and immunohistochemistry (where both membranous and cytoplasmic staining were present). Duox2 expression detected by Duox S-12 was functionally coupled to the generation of H2O2, in pancreatic cancer cells that expressed Duox2 and its cognate maturation factor DuoxA2. Although Duox S-12 recognizes ectopically expressed Duox1 protein because of the extensive amino acid homology between Duox1 and Duox2, the lack of substantial Duoxl mRNA expression in human tumors (except thyroid cancer) allowed us to evaluate Duox2 expression across a wide range of normal and malignant tissues by immunohistochemistry. Duox2 was expressed at elevated levels in many human cancers, most notably tumors of the prostate, lung, colon and breast while brain tumors and lymphomas demonstrated the lowest frequency of expression. The Duox-specific monoclonal antibody described here provides a promising tool for the further examination of the role of Duox-dependent reactive oxygen production in inflammation-related carcinogenesis, where alterations in oxidant tone play a critical role in cell growth and proliferation.
引用
收藏
页码:1229 / 1238
页数:10
相关论文
共 50 条
  • [21] Functional heterogeneity in tumor-derived human pancreatic stellate cells: Differential expression of HGF and implications for mitogenic signaling and migration in pancreatic cancer cells
    Tjomsland, Vegard
    Aasrum, Monica
    Christoffersen, Thoralf
    Gladhaug, Ivar P.
    ONCOTARGET, 2017, 8 (42) : 71672 - 71684
  • [22] Molecular expression and functional activity of vitamin C specific transport system (SVCT2) in human breast cancer cells
    Khurana, Varun
    Kwatra, Deep
    Pal, Dhananjay
    Mitra, Ashim K.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 474 (1-2) : 14 - 24
  • [23] Novel Tumor Antigen-Specific Monoclonal Antibody-Based Immunotherapy to Eradicate Both Differentiated Cancer Cells and Cancer-Initiating Cells in Solid Tumors
    Sabbatino, Francesco
    Wang, Yangyang
    Wang, Xinhui
    Schwab, Joseph H.
    Ferrone, Soldano
    Ferrone, Cristina R.
    SEMINARS IN ONCOLOGY, 2014, 41 (05) : 685 - 699
  • [24] Hexokinase type II: A novel tumor-specific promoter for gene-targeted therapy differentially expressed and regulated in human cancer cells
    Katabi, MM
    Chan, HLB
    Karp, SE
    Batist, G
    HUMAN GENE THERAPY, 1999, 10 (02) : 155 - 164
  • [25] ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models
    Cho, B. C.
    ANNALS OF ONCOLOGY, 2015, 26 : 38 - 38
  • [26] ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models
    Kang, Han Na
    Kim, Se-Ho
    Yun, Mi Ran
    Kim, Hye Ryun
    Lim, Sun Min
    Kim, Min-Soo
    Hong, Kwang-Won
    Kim, Sung-Moo
    Kim, Hwan
    Pyo, Kyoung-Ho
    Park, Hye Ji
    Han, Joo Yeun
    Youn, Hyun A.
    Chang, Ki-Hwan
    Cho, Byoung Chul
    LUNG CANCER, 2016, 95 : 57 - 64
  • [27] Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor
    Moon, Edmund K.
    Carpenito, Carmine
    Sun, Jing
    Wang, Liang-Chuan S.
    Kapoor, Veena
    Predina, Jarrod
    Powell, Daniel J., Jr.
    Riley, James L.
    June, Carl H.
    Albelda, Steven M.
    CLINICAL CANCER RESEARCH, 2011, 17 (14) : 4719 - 4730
  • [28] EVIDENCE FOR THE EXPRESSION OF HUMAN TUMOR-SPECIFIC ANTIGENS ASSOCIATED WITH BETA-2-MICROGLOBULIN IN HUMAN CANCER AND IN SOME COLON ADENOMAS AND BENIGN BREAST LESIONS
    THOMSON, DMP
    TATARYN, DN
    OCONNOR, R
    RAUCH, J
    FRIEDLANDER, P
    GOLD, P
    SHUSTER, J
    CANCER RESEARCH, 1978, 39 (02) : 604 - 611
  • [29] Human monoclonal antibody for ovarian clear cell carcinoma-2, a human monoclonal antibody with antitumor activity against ovarian cancer cells that recognizes CA125-like antigen
    Suzuki, N.
    Tamada, Y.
    Shigirahara, K.
    Suzuki, A.
    Susumu, N.
    Ishida, I.
    Aoki, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (05) : 996 - 1006
  • [30] Inhibition of Bcl-2 expression by a novel tumor-specific RNA interference system increases chemosensitivity to 5-fluorouracil in Hela cells
    Sheng-lin HUANG Yi WU Hai YU Ping ZHANG Xing-qian ZHANG Lei YING Han-fang ZHAO Research Center for Human Gene Therapy
    Acta Pharmacologica Sinica, 2006, (02) : 242 - 248